White House says removal of AstraZeneca vaccine from U.S. plant will not affect dose output

A U.S. government decision to end production of AstraZeneca's COVID-19 vaccine at Emergent BioSolutions Inc's Baltimore manufacturing facility is not an indication of concerns about its safety or effectiveness and will not impact the output of doses, a White House official said on Monday.

Reuters | Washington DC | Updated: 05-04-2021 23:07 IST | Created: 05-04-2021 23:04 IST
White House says removal of AstraZeneca vaccine from U.S. plant will not affect dose output
Representative Image Image Credit: ANI

A U.S. government decision to end production of AstraZeneca's COVID-19 vaccine at Emergent BioSolutions Inc's Baltimore manufacturing facility is not an indication of concerns about its safety or effectiveness and will not impact the output of doses, a White House official said on Monday. The U.S. Department of Health and Human Services (HHS) ordered Johnson & Johnson to take charge of production at the plant that was being used to produce both vaccines. Emergent was told to stop making AstraZeneca's shot after the contract manufacturer made an error that ruined 15 million J&J COVID-19 vaccine doses.

"This is not a decision that in any way has anything to do with any concerns about the AstraZeneca vaccine," White House COVID-19 adviser Andy Slavitt told reporters during a virtual news conference. The AstraZeneca shot, which is being used in dozens of countries, has been under increased scrutiny over reports of extremely rare but serious blood clots in the brain in some people who received the vaccine.

The U.S. manufacturing mistake occurred several weeks ago, when it was discovered that a batch of J&J vaccine had been contaminated with ingredients from AstraZeneca's vaccine, the New York Times reported last week. J&J on Saturday reiterated that it will deliver 100 million doses to the government by the end of May. Emergent said on Sunday would ramp down production of AstraZeneca's COVID-19 vaccine at the Baltimore plant.

AstraZeneca, whose vaccine has not yet been authorized for use in the United States, said it will work with President Joe Biden's administration to find an alternative production site. "This is a decision that HHS made with Johnson & Johnson and AstraZeneca in complete collaboration," Slavitt said.

Slavitt also said during Monday's briefing that nearly one-in-three Americans have had at least one COVID-19 shot and more than 55% of seniors have been fully vaccinated. However, average daily coronavirus infections have increased 7% over the previous seven-day period to around 64,000 daily, Dr. Rochelle Walensky, head of the U.S. Centers for Disease Control and Prevention, told reporters on Monday.

The United States has shipped out nearly 208 million COVID-19 shots and administered more than 165 million, according to federal data last updated on Sunday.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Blockchain in Healthcare: Opportunities and challenges

The use of blockchain in healthcare is a relatively new innovation with many of its uses still being explored and related technologies being developed, improved, and scaled. ...

Debate surrounding vaccine passports and development misses bigger picture

... ...

Blockchain vs IOTA: Looking for a better alternative

... ...

For stability, Iraq needs to crack down on corruption

... ...

Videos

Latest News

Australia races to trace source of COVID-19 mystery case in Sydney

Australian authorities were racing to track the source of a mystery COVID-19 infection in Sydney on Thursday, the first locally transmitted case in the city in more than a month, warning residents to brace for more cases.Health officials ar...

Andhra Police holds COVID-19 awareness rally as state observes partial lockdown

As part of the partial curfew and Section 144 imposed in Andhra Pradesh, the Srikakulam district police on Wednesday held a COVID-19 awareness rally with 10 vehicles in all major junctions of the town. Deputy Superintendent of Police Mahend...

EXCLUSIVE-U.S. targets Central America officials for possible sanctions over corruption -envoy

The Biden administration plans to release by the end of June a list of corrupt Central American officials who may be subject to sanctions, a U.S. special envoy told Reuters, as Washington seeks to cut back on a root cause of increased migra...

Brazil court suspends probe into Indigenous leader who criticized Bolsonaro

A Brazilian judge on Wednesday suspended a police probe into a top Indigenous leader who had criticized the government of President Jair Bolsonaro for its handling of the COVID-19 crisis, which has had a devastating impact on native peoples...

Give Feedback